Literature DB >> 1838071

Initiation of insulin treatment after 70 years of age: patient status 2 years later.

F Elgrably1, D Costagliola, A J Chwalow, P Varenne, G Slama, G Tchobroutsky.   

Abstract

The present study assessed 106 diabetic patients 2 years after beginning insulin treatment at or after 70 years of age. Ten patients (9%) had had the therapy discontinued after 2-4 months, 26 (25%) had died of causes unrelated to insulin therapy, 12 (11%) were lost to follow-up, and 58 (55%) were still alive and insulin treated. Fifty-one were at home and seven institutionalized for reasons unrelated to insulin therapy. Of these 58 patients, 50 were available for further study. Except for frequency of travel, which had decreased, lifestyle either improved or did not change. Patients' perceptions of the goals of treatment were more appropriate to a younger population of patients, who are less vulnerable to hypoglycaemic reactions. Mean fasting blood glucose was considered by the medical staff to be too low in 42% of cases. Adding insulin to the treatment of the elderly did not negatively affect their lifestyle, and indeed, insulin therapy appeared to create or strengthen the patients' existing social support network. Educational interventions must attempt to extend the effect of the specialized unit outside the hospital, to families, visiting nurses as well as general practitioners.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838071     DOI: 10.1111/j.1464-5491.1991.tb01699.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

Review 1.  Quality of life in type II diabetes: evaluation and applications.

Authors:  C Eiser; J E Tooke
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

2.  Quality of life following a change in therapy for diabetes mellitus.

Authors:  M Pibernik-Okanović; S Szabo; Z Metelko
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 3.  Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus.

Authors:  C D Saudek; S Hill Golden
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

4.  Tablet and insulin therapy in type 2 diabetes in the elderly.

Authors:  A H Barnett
Journal:  J R Soc Med       Date:  1994-10       Impact factor: 5.344

Review 5.  Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.

Authors:  A N Goudswaard; N J Furlong; G E H M Rutten; R P Stolk; G D Valk
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

6.  The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.

Authors:  Moshe Phillip; Richard M Bergenstal; Kelly L Close; Thomas Danne; Satish K Garg; Lutz Heinemann; Irl B Hirsch; Boris P Kovatchev; Lori M Laffel; Viswanathan Mohan; Christopher G Parkin; Tadej Battelino
Journal:  Diabetes Technol Ther       Date:  2020-09-28       Impact factor: 6.118

7.  Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient- and physician-related factors): A prospective observational DIPP-FACTOR study in Korea.

Authors:  Sin Gon Kim; Nam Hoon Kim; Bon Jeong Ku; Ho Sang Shon; Doo Man Kim; Tae Sun Park; Yong-Seong Kim; In Joo Kim; Dong Seop Choi
Journal:  J Diabetes Investig       Date:  2017-03-30       Impact factor: 4.232

Review 8.  Insulin use in elderly diabetic patients.

Authors:  Scott K Ober; Sharon Watts; Renée H Lawrence
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

9.  Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.

Authors:  Kamlesh Khunti; Michael L Wolden; Brian Larsen Thorsted; Marc Andersen; Melanie J Davies
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

10.  Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study.

Authors:  Leon Litwak; Su-Yen Goh; Zanariah Hussein; Rachid Malek; Vinay Prusty; Mohammad E Khamseh
Journal:  Diabetol Metab Syndr       Date:  2013-10-24       Impact factor: 3.320

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.